The Newest PAMA Controversy: The GAO Report & Intervention of a Powerful Senator

 Email not displaying correctly? View it in your browser.
  Lab and Pathology Insider Logo  
April 2, 2019  
placeholder FALSE CLAIMS
Compliance Perspectives: How to Spot & Avoid Kickback Risks under New EKRA Law
From Lab Compliance Advisor
A new law passed to deal with the opioid epidemic has significant ramifications for labs including but not limited to those involved in drug addiction and…
Read More
placeholder DRUG TESTING
Enforcement Trends: CMS Looks to Recover $66.3 Million in Improper Specimen Validity Test Payments
From National Intelligence Report
The opioid crackdown has made urine drug testing an even greater priority for federal health fraud enforcers. One principle target is specimen validity testing…
Read More
placeholder NEW PRODUCTS
The Dx Pipeline: A Roundup of the Month's Key New Product Launches
From Laboratory Industry Report
March was the most intense month of the year so far for new diagnostic products highlighted by 23andMe's launch of a new…
Read More
placeholder GENETIC TESTING
ASCO Endorses CAP's Practice Guidelines for HPV Testing in Head, Neck Cancers
From Diagnostic Testing & Emerging Technologies
The American Society of Clinical Oncology endorsed the American Pathologists' practice guidelines for human papillomavirus (HPV) testing in…
Read More
placeholder LIVE WEBINAR: APR. 25 @ 1 PM EASTERN
2019 Clinical Lab Fraud & Abuse Update
Presenter - Danielle Sloane - Partner, Bass, Berry & Sims
Join us on April 25th to hear from Danielle Sloane, Partner at Bass, Berry & Sims and noted lab compliance expert, who will discuss…
Click Here to Register

For questions concerning delivery of this email, please contact customer service at:
(888) 729-2315 | customerservice@plainlanguagemedia.com

Copyright © 2019, All rights reserved.
Plain Language Media LLLP
PO Box 509, New London, CT 06320